During HLM Rare 2025 we launched the Declaration on the European Innovation and Care Ecosystem for Rare and Complex Diseases. This Declaration is a political and strategic commitment to fundamentally transform our ecosystem. It sets out a bold shared vision, clear strategic priorities, and a roadmap that includes, in the short term, the establishment of a Consultative Group to develop a concrete, measurable Action Plan, and in the medium to long term, accelerated progress for rare and complex diseases—through more treatments, universalised newborn screening, and advanced diagnostics. Over the three days of our event, each panel discussed, tested, and refined specific priorities and recommendations that the Declaration puts forward, so that this document becomes not just a statement of intent, but a practical guide for joint action in the years ahead .
Who signed the Declaration
HLM Rare 2025 Hosts
• Vytenis Andriukaitis , Member of the European Parliament (S&D, Lithuania) and host of the High-Level Meeting
• Maurizio Scarpa , Founder and Co-Chair of Brains for Brain Foundation, Coordinator European Reference Network for Hereditary Metabolic Diseases (MetabERN), and host of the High-Level Meeting
European Reference Networks
• Alexis Arzimanoglou , European Reference Network for Rare and Complex Epilepsies (EpiCare) Coordinator
• Hélène Dollfus , European Reference Network for rare eye diseases (ERN-EYE) Coordinator
• Holm Graessner , European Reference Network for Neurological Disorders (ERN-RND) Coordinator
• Peter Mulders , European Reference Network for Rare Uro-Recto-Genital Diseases and Complex Conditions (EUROGEN) Coordinator
• Ruth Ladenstein , European Reference Network for Paediatric Oncology (PaedCan) Coordinator
• Marjolijn Ligtenberg , European Reference Network on genetic tumour risk syndromes (ERN GENTURIS) Coordinator
• Marta Mosca , European Reference Network of Connective Tissue and Musculoskeletal diseases (ERN ReCONNET) Coordinator
• Mari Murel , ERN Guard-Heart Network Project Manager
• Mar Mañu Pereira , European Reference Network on Rare Hematological Diseases (ERN-EuroBloodNet) Coordinator
• Alberto Pereira , European Reference Network for Rare Endocrine Conditions (Endo – ERN) Coordinator, Adult Chair
• Alessandra Renieri , European reference network for rare malformation syndromes and rare intellectual and neurodevelopmental disorders (ERN ITHACA) Project Manager
• Luca Sangiorgi , European Reference Network on Rare Bone Diseases (ERN-BOND) Coordinator
• René Wijnen , European Reference Network for rare Inherited and Congenital (digestive and gastrointestinal) Anomalies (ERNICA) Coordinator
• Anneke Werk , European Reference Network on on hepatological diseases (ERN RARE-LIVER) Project Manager
Members of the European Parliament
• Christel Schaldemose , Vice-President of the European Parliament and Member of the European Parliament (S&D, Denmark)
• Stine Bosse , Member of the European Parliament (Renew, Denmark)
• Nicolás González Casares , Member of the European Parliament (S&D, Spain) and member of Panel for the Future of Science and Technology (STOA)
• Adam Jarubas , Member of the European Parliament (EPP, Poland) and Chair of the SANT Committee
• Nikos Papandreou , Member of the European Parliament (S&D, Greece)
• Tomislav Sokol , Member of the European Parliament (EPP, Croatia)
• András Tivadar Kulja , Member of the European Parliament (EPP, Hungary)
• Aurelijus Veryga , Member of the European Parliament (ECR, Lithuania)
• Vlad Voiculescu , Member of the European Parliament (Renew, Romania)
Patient Organisations
• Avril Daly , President, EURORDIS-Rare Diseases Europe
• Dariusz Adamczewski , Managing Director, Children’s Tumor Foundation Europe
• Teresa Pais , Senior Policy Officer, Childhood Cancer International Europe
• Johan Prevot , Executive Director, International Patient Organisation for Primary Immunodeficiencies (IPOPI)
• Kacper Ruciński , Public Health Expert, SMA Foundation Poland
• Dominique Sturz , ERN Eye ePAG chair
Professional Societies & Research Institutes/organisations/projects
• James R. Bonham , President of the International Society of Neonatal Screening (ISNS)
• Silvio Brusaferro , Former President, Italian Institute of Health (2019-2023)
• Alessandra Ferlini , University of Ferrara, Italy & Scientific Coordinator of the EU-IHI Screen4Care project
• Liesbet Geris , Professor Biomedical Engineering, Université of Liège and KU Leuven; Executive Director VPH Institute, Belgium
• Ralf Dieter Hilgers , RealiseD Coordinator and Sigmund Freud Private University Vienna
• Daria Julkowska , European Rare Diseases Research Alliance (ERDERA) Coordinator
• Michael Marmot , Director of the UCL Institute of Health Equity, London
• Leonidas A. Phylactou , CEO and Medical Director, The Cyprus Institute of Neurology and Genetics
• Ana Rath , Orphanet Director, INSERM
• Till Voigtländer , Coordinator JARDIN Joint Action
Industry
• Anne-Sophie Chalandon , Head of Global Rare Disease Policy, Sanofi
• Giacomo Chiesi , Executive Vice President, Global Rare Diseases, Chiesi Group
• Jane Cooper , Senior Vice-President, Head of EMEA, Ultragenyx
• Nathalie Moll , Director General of the European Federation of Pharmaceutical Industries and Associations
• Alexander Natz , Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
• Michael Ostland , Head of Development Europe, Denali Therapeutics
• Boris Sevarika , NanoZymeX
• Alberta M.C. Spreafico , Senior Vice President Health Innovation, EVERSANA; President, Innovation for Global Health Institute